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Abstract: Recently, Saeb et al (2017) showed that, in diagnostic machine
learning applications, having data of each subject randomly assigned to
both training and test sets (record-wise data split) can lead to massive
underestimation of the cross-validation prediction error, due to the pres-
ence of “subject identity confounding” caused by the classifier’s ability to
identify subjects, instead of recognizing disease. To solve this problem, the
authors recommended the random assignment of the data of each subject
to either the training or the test set (subject-wise data split). The adop-
tion of subject-wise split has been criticized in Little et al (2017), on the
basis that it can violate assumptions required by cross-validation to con-
sistently estimate generalization error. In particular, adopting subject-wise
splitting in heterogeneous data-sets might lead to model under-fitting and
larger classification errors. Hence, Little et al argue that perhaps the over-
estimation of prediction errors with subject-wise cross-validation, rather
than underestimation with record-wise cross-validation, is the reason for
the discrepancies between prediction error estimates generated by the two
splitting strategies. In order to shed light on this controversy, we focus on
simpler classification performance metrics and develop permutation tests
that can detect identity confounding. By focusing on permutation tests, we
are able to evaluate the merits of record-wise and subject-wise data splits
under more general statistical dependencies and distributional structures
of the data, including situations where cross-validation breaks down. We
illustrate the application of our tests using synthetic and real data from a
Parkinson’s disease study.
1. Introduction
The data-driven diagnosis of diseases is currently a major focus of applied ma-
chine learning research. Under the supervised learning paradigm, a classifier of
disease status (i.e., cases versus controls) is built by training the machine learn-
ing classifier on example data consisting of input variables (features) and an
output variable (case and control labels), and then making predictions about
unseen labels based on newly observed feature data.
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An important element of this endeavor is to assess the prediction performance
of the trained classifier. The key point is to evaluate the performance of the al-
gorithm on a completely separate data-set (test set) other than the one used
to train the classifier (training set), so that the algorithm doesn’t make cor-
rect label predictions just because it “remembers” the examples it already saw.
However, because diagnostic systems based on mobile health applications are
able to collect dense longitudinal data on each user, the question then arises on
how should one split the data when evaluating the performance of a diagnostic
machine learning system[1]. Should the data be split in a subject-wise fashion,
where all the longitudinal data of each participant is randomly assigned to either
the training set or to the test set? Or should the data be split in a record-wise
manner, where it is randomly split into training and test sets irrespective of
which subjects it belongs to, so that the data from the same subject can belong
to both training and test sets?
Recently, Saeb et al [1] demonstrated via simulation studies and the analysis
of a publicly available data-set that (for diagnostic applications) splitting the
data into training and test sets in a record-wise fashion can lead to massive
underestimation of prediction error computed via cross-validation, and that,
instead, researchers should adopt subject-wise training/testing data splits. As
pointed by the authors, the problem arises because in a record-wise split, the
data from each subject can be in both the training and test sets, so that the
algorithm is mostly learning about the subject’s individual characteristics in
the feature data (i.e., it is mostly performing subject identification), instead of
learning about the disease characteristics (i.e, performing disease recognition).
In other words, the relationship between feature data and disease labels learned
by the classifier is confounded by the identity of the subjects (from now on
denoted as “identity confounding”). Now, because the easier task of subject
identification replaces the harder task of disease recognition, classifiers trained
on data split in a record-wise manner end up achieving overly optimistic pre-
diction accuracy estimates[1]. (The dangers of record-wise data splitting were
independently raised by Sarkar et al [2, 3], who proposed a “leave-one-individual-
out” validation scheme, and by Chaibub Neto et al [4], where the presence of
the identity confounding, denoted as the “digital fingerprint” in that work, was
demonstrated by showing that disease status classifiers were able to achieve
high classification accuracies, even when the disease labels were shuffled in a
subject-wise fashion.)
In an accompanying discussion article, Little et al [5] warns about poten-
tial issues that might arise from the uncritical adoption of subject-wise cross-
validation in diagnostic applications. While there was a consensus that the work
of Saeb et al demonstrated that identity confounding can be an important issue
in practical situations, Little et al pointed out situations where subject-wise data
splitting violates the assumptions required by cross-validation for the consistent
estimation of generalization error. In particular, the adoption of subject-wise
splitting with highly heterogeneous data, where it is hard to avoid a mismatch
between training and test sets, can make it difficult to train models, and might
lead to systematic under-fitting and larger classification errors. Hence, Little et
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al argue that whenever the generalization error estimated with record-wise cross-
validation is much lower than with subject-wise cross-validation it is possible
that model under-fitting, and not identity confounding, is driving the discrep-
ancy.
Here, we focus on a more manageable problem than the estimation of pre-
diction error via cross-validation, and propose a statistical approach to separate
these two situations. We simplify the problem on two fronts. First, we focus
on simpler performance metrics than the cross-validation error. (Note that, we
don’t really need to estimate generalization error in order to show that a classifier
performs differently depending on how we split the data. Instead, the compari-
son of any classification performance metric suffices to show the discrepancy. As
a matter of fact, the area under the receiver operating characteristic curve was
used in Chaibub Neto et al [4], to illustrate the discrepancy.) Second, we focus
on hypothesis testing, rather than error estimation. Explicitly, we build on the
subject-wise label permutation argument used by Chaibub Neto et al [4] to illus-
trate the presence of identity confounding, and develop two permutation tests.
The first test allows us to determine whether the classifier is performing disease
recognition, even when identity confounding is present. The second test, builds
on the first, and allows us to test for the presence of identity confounding/digital
fingerprints per se. By focusing on permutation tests, whose only assumption
is the exchangeability of the data under the null hypothesis, we are able to
check for identity confounding under more general statistical dependencies and
distributional structures of the data, including situations where cross-validation
breaks down.
We illustrate the application of the proposed permutation tests with synthetic
data examples, as well as, real data from a Parkinson’s disease study[11, 10].
The synthetic data examples illustrate that identity confounding can arise for
many different reasons, including serial dependency in the feature data of each
participant (i.e., serially associated records), as well as, due to location and
scale differences in the feature distributions across the subjects (even when the
longitudinal feature measurements are independent of each other). The real data
examples illustrate that a high degree of identity confounding can be present in
digital health applications.
The rest of this paper is organized as follows. Section 2 describes the per-
mutation tests. Section 3 illustrates their application to synthetic and real data
examples. Finally, Section 4 presents a discussion of our results.
2. The proposed permutation tests
Before describing the permutation tests, we first introduce some notation. Through-
out the text we let s = {1, 2, . . . , Ns} index the subjects, rs = {1, 2, . . . , Nrs}
index the records across subject s, and f = {1, 2, . . . , Nf} index the features.
X represents the (NsNrs)×Nf matrix of feature data, with columns indexing
the features, and rows indexing the records across all Ns subjects, while y rep-
resents the corresponding vector of disease labels, with dimension (NsNrs)× 1.
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We let m represent an arbitrary classification performance metric, and reserve
p to represent the number of permutations employed in our tests. We let A and
B represent the events,
A ≡ the classifier is performing disease recognition,
B ≡ the classifier is performing subject identification,
and adopt standard set theory notation where: Ec represents the complement of
event E; ∅ represents the empty set; Ω represents the universe; and the symbols
∪ and ∩ represent the union and intersection of events, respectively.
2.1. Assessing whether the classifier is performing disease
recognition
In order to evaluate whether the classifier is performing disease recognition (even
when identity confounding is present) we need to generate a permutation null
distribution where the association between the disease labels and the features is
destroyed while the association between the features and the subject identities is
still preserved. To this end, we generate a permutation distribution by shuffling
the disease labels in a subject-wise fashion, as described in Algorithm 1, and
illustrated in Figures 1 and 2, and test the hypotheses,
H∗0 : the classifier is not performing disease recognition,
H∗1 : the classifier is performing disease recognition
Algorithm 1 Permutation null distribution for disease recognition
1: Input: Number of permutations, p; feature data matrix, X; label data vector, y; training
and test set indexes, itrain, itest
2: Split X into training and test feature sets, Xtrain ←X[itrain, ], Xtest ←X[itest, ]
3: for i = 1, 2, . . . , p do
4: Generate a subject-wise shuffled version of the label data, y∗
5: Split y∗ into training and test label sets, y∗train ← y∗[itrain], y∗test ← y∗[itest]
6: Train a classifier on the Xtrain and y
∗
train data
7: Evaluate the classifier performance on the Xtest and y∗test data
8: Record the value of the performance metric, m∗i , on the shuffled data
9: end for
10: Output: m∗1, m
∗
2, . . . , m
∗
p
Note that because we are using the performance metric,m, as the test statistic
of the permutation test (and m is able to capture the contributions of both
disease recognition and subject identification to the classification performance),
we have that the alternative hypothesis H∗1 is equivalent to “the classifier is
performing disease recognition irrespective of whether it is also doing subject
identification or not”. In other words, H∗1 can be more precisely parsed as,
H∗1 : A ∩ (B ∪Bc) = A ∩ Ω = A , (1)
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while it’s complement, the null H∗0 , can be parsed as,
H∗0 : (H
∗
1 )
c = Ac ∪ (B ∪Bc)c = Ac ∪ (Bc ∩B) = Ac ∪ ∅ = Ac . (2)
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Fig 1. Generation of the disease recognition permutation null distribution, using the record-
wise data split strategy to create the training and test sets. The schematic shows a few ex-
amples of subject-wise shuffled labels, for a data-set with 8 subjects (4 cases and 4 controls),
where each subject contributed 2 records. For instance, in the first permutation, the labels of
subjects 2 and 3 changed from “case” to “control”, the labels of subjects 5 and 8 changed from
“control” to “case”, and the labels of subjects 1, 4, 6, and 7 remained the same. (Note that
for each subject, the labels are changed across all records.) Adopting the record-wise data split
strategy, with one half of the records assigned to the training set, and the other half to the
test set, we have that both training and test sets contain 1 sample from each of the subjects.
A permutation p-value for testing H∗0 is computed as the proportion of times
that the performance metric computed in shuffled label data was better than
the performance metric computed with the original (un-shuffled) labels, mo. For
instance, for a performance metric such as the area under the receiver operating
characteristic curve (AUC), where larger values indicate better classification
performance, the permutation p-value can be estimated as
p∑
i=1
11{m∗i ≥ mo}/p , (3)
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Fig 2. Generation of the disease recognition permutation null distribution, using the subject-
wise data split strategy to create the training and test sets. The schematic shows a few ex-
amples of subject-wise shuffled labels, for a data-set with 8 subjects (4 cases and 4 controls),
where each subject contributed 2 records. (Note that for each subject, the labels are changed
across all records.) Adopting the subject-wise data split strategy, with half of the subjects as-
signed to the training set, and the other half to the test set, we have that all the records of
each subject are either assigned to the training set, or to the test set.
where 11 represents the indicator function, assuming value 1, when m∗i ≥ mo,
and 0, otherwise. (For performance metrics where smaller values indicate better
classification performance, such as misclassification rate, the permutation p-
value is given by
∑p
i=1 11{m∗i ≤ mo}/p.)
Figures 1 and 2 illustrate the generation of the subject-wise permutation null
distribution when the training/test data is split in a record-wise fashion and in
subject-wise manner, respectively. Note that when the data is split in a record-
wise fashion, and identity confounding is present, the disease recognition null
distribution will be centered away from the baseline random guess value (e.g.,
0.5 when adopting the AUC) since in the generation of the null distribution
the label data is split into training and test sets only after the labels were
shuffled (see steps 4 to 7 of Algorithm 1). As a consequence, the presence of
identity confounding will show up as an ability to classify the permuted labels
with an accuracy that is better than a random guess (since even though the
shuffling of labels prevent the algorithm from performing disease recognition,
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it is still able to perform subject identification). For example, when adopting
the AUC metric, and in the presence of strong identity confounding, the disease
recognition null will be centered at AUC values closer to 1 than to 0.5. Hence,
the disease recognition null distribution not only allows us to test whether the
classifier is performing disease recognition, but also informally allows us to infer
the presence of identity confounding by simply inspecting how far it is centered
from the baseline random guess value. (Observe, nonetheless, that for data split
in a subject-wise fashion, the disease recognition null distribution will always be
centered around the baseline random guess value, since identity confounding is
neutralized by subject-wise data split.) Finally, note that the proposed disease
recognition permutation test assumes that the disease labels are exchangeable
across subjects (in a subject-wise fashion) under the null H∗0 .
2.2. Detecting identity confounding
As described above, the presence of identity confounding will shift the disease
recognition null distribution away from the baseline random guess value. Hence,
the median of the disease recognition null distribution,
m˜∗ = median(m∗1,m
∗
1, . . . ,m
∗
p) , (4)
represents a natural statistic to quantify identity confounding alone, as it mea-
sures the contribution of identity confounding to the classifier’s predictive abil-
ity, after the algorithm’s ability to recognize disease has been neutralized by the
subject-wise shuffling of disease labels. (Note that while other statistics such
as the mean of the disease recognition null distribution could be used to quan-
tify identity confounding, we prefer the more robust median metric since the
distribution can be asymmetric.)
In order to test whether the classifier is performing subject identification, we
need to generate a permutation null distribution (for the m˜∗ statistic) where
the association between the subject identities and the features is broken. To this
end, we shuffle the feature data in a record-wise fashion, before computing the
m˜∗ statistic, as described in Algorithm 2, and illustrated in Figure 3.
Note that because the record-wise shuffling of the feature data also breaks the
association between the features and the disease labels, the identity confounding
null distribution will always be centered around the baseline random guess value
(0.5 for the AUC metric).
For performance metrics where larger values indicate better classification
performance, the permutation p-value for testing the hypotheses,
H∗∗0 : the classifier is not performing subject identification
H∗∗1 : the classifier is performing subject indentification,
is estimated as,
p∑
i=1
11{m˜∗∗i ≥ m˜∗}/p , (5)
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Algorithm 2 Permutation null for detecting identity confounding
1: Input: Number of feature permutations, p; number of label permutations, pl; feature data
matrix, X; label data vector, y; training and test set indexes, itrain, itest
2: for i = 1, 2, . . . , p do
3: Generate a record-wise shuffled version of the feature data, X∗
4: Split X∗ into training and test sets, X∗train ←X∗[itrain, ], X∗test ←X∗[itest, ]
5: for j = 1, 2, . . . , pl do
6: Generate a subject-wise shuffled version of the label data, y∗
7: Split y∗ into training and test label sets, y∗train ← y∗[itrain], y∗test ← y∗[itest]
8: Train a classifier on the X∗train and y
∗
train data
9: Evaluate the classifier performance on the X∗test and y∗test data
10: Compute the value of the performance metric, m∗∗j , on the shuffled data
11: end for
12: Record the median of the perf. metric distr., m˜∗∗i = median(m
∗∗
1 ,m
∗∗
1 , . . . ,m
∗∗
pl
)
13: end for
14: Output: m˜∗∗1 , m˜
∗∗
2 , . . . , m˜
∗∗
p
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Fig 3. Record-wise feature shuffle. The schematic illustrates one instance of record-wise fea-
ture shuffling for a data-set containing 8 subjects (4 cases and 4 controls), and 2 records per
subject. Record-wise feature shuffling breaks the connection between the features and the sub-
ject identities, as well as, between the features and the disease labels. For instance, the green
arrow shows that record 10, which was originally associated with subject 5 and a “control”
label in the observed data, is paired with subject 4 and a “case” label in the shuffled data.
where m˜∗ represents the observed value of the test statistic, computed on the
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original (un-shuffled) feature data, and defined in equation (4), whereas m˜∗∗i
represents the statistic computed on the shuffled feature data, as described in
step 12 of Algorithm 2. (Otherwise, it is computed as
∑p
i=1 11{m˜∗∗i ≤ m˜∗}/p.)
Note that when we shuffle the feature data in a record-wise fashion we, of
course, break the connection between the feature data and both the subject iden-
tities and the disease labels. We point out, nonetheless, that the null hypothesis
H∗∗0 is given by H
∗∗
0 : B
c and not by H∗∗0 : B
c ∩ Ac because, by construction,
our test statistic only captures the contribution of the subject identification to
the classifier’s performance. Observe, as well, that the identity confounding per-
mutation test assumes the exchangeability of the feature data (in a record-wise
fashion) under the null H∗∗0 .
One important drawback of this permutation test is the high amount of com-
putation required to generate the null distribution. We point out, however, that
for the particular case where the AUC metric is adopted to evaluate the classifier
performance, it is sometimes possible to infer the presence of identity confound-
ing using an analytical approach without having to run the permutation test.
2.3. An analytical shortcut for detecting identity confounding, based
on the AUC metric
Here, we describe an alternative approach to detect identity confounding. While
it is not a proper statistical test, it provides a statistic similar to a p-value
(denoted a “pseudo p-value”) which can still be useful in practice. But, before
presenting the pseudo p-value statistic, we first describe an additional statistical
test that helps understand the pseudo p-value approach.
Consider a third permutation test, where we adopt the AUC as the test
statistic, and generate a null distribution by shuffling the disease labels in a
record-wise fashion. In this case, because the AUC metric is able to capture
the contributions of both disease recognition and subject identification to the
classification performance, and the record-wise shuffling of labels breaks the con-
nection between the disease labels and both the feature data and the subject
identities, we have that the permutation procedure is now testing the null hy-
pothesis Ac ∩Bc against the alternative A∪B. Hence, the permutation p-value
for testing this third set of hypothesis,
H∗∗∗0 : the classifier is not performing disease recognition
and subject identification,
H∗∗∗1 : the classifier is performing disease recognition,
or subject identification.
is computed as,
p∑
i=1
11{auc∗i ≥ auc0}/p , (6)
where auc0 represents the AUC value computed from the original data.
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For this statistical test, nonetheless, an analytical solution is available. Explic-
itly, it has been shown[6] that, when there are no ties in the predicted class prob-
abilities used for the computation of the AUC, the test statistic of the Mann-
Whitney U test (U) is related to the AUC statistic by, U = nn np(1 − AUC),
where nn and np represent the number of negative and positive labels in the
test set (see section 2 of reference[7] for details).
In the presence of ties, the p-value can be computed as the left tail of the
asymptotic approximate null,
U ≈ N
nn np
2
,
nn np(n+ 1)
12
− nn np
12n (n− 1)
τ∑
j=1
tj(tj − 1)(tj + 1)
 , (7)
where n = nn + np, τ is the number of groups of ties, and tj is the number of
ties in group j[7].
Alternatively, we can get the p-value as the right tail probability of the cor-
responding AUC null, AUC ≈ N(0.5 , φ2),
p-value = 1− Φ
(
auc0 − 0.5
φ
)
, (8)
where Φ() represents the cumulative distribution function of a standard normal
distribution, and,
φ2 =
n+ 1
12nn np
− 1
12nn np n (n− 1)
τ∑
j=1
tj(tj − 1)(tj + 1) . (9)
Here, we propose to use the pseudo p-value statistic,
pseudo p-value ≡ 1− Φ
(
˜auc∗0 − 0.5
φ
)
, (10)
as an alternative measure for identity confounding, where ˜auc∗0 corresponds to
the median of the disease recognition null distribution computed using the AUC
metric.
Note that this procedure does not correspond to a proper statistical test,
since it compares the value of one test statistic against the null distribution
of a different test statistic, effectively performing an “apples-to-bananas” com-
parison (namely, it compares the median of the AUC metric under the disease
recognition null distribution against the distribution of the AUC metric under
H∗∗∗0 ). (The correct comparison is the one described in the previous section,
where we compare the observed median statistic ˜auc∗0 to the null distribution
for the same statistic, generated according to Algorithm 2.)
In any case, the pseudo p-value might be still useful in practice, because
the null distribution of the AUC statistic under H∗∗∗0 will always have a larger
spread than the null distribution of the median AUC statistic under H∗∗0 (since,
when we shuffle the feature data in a record-wise fashion, we have that the
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disease recognition null distribution will be centered at values close to 0.5, so
that it’s median value will tend to be very close to 0.5). Hence, if the pseudo
p-value is already very small, there is no need to perform the computationally
expensive permutation test for detecting identity confounding. We point out,
however, that a non-significant pseudo p-value does not necessarily mean lack
of identity confounding, and that, in this case, it is necessary to compute the
permutation p-value since identity confounding can still be present when the
pseudo p-value suggests it is not.
3. Illustrative examples
We illustrate the application of our permutation tests using synthetic and real
data-sets, split into training and test sets according to both the record-wise
and subject-wise data split strategies. In all illustrations, we adopt the AUC
as the performance metric, and employ the random forest classifier[8] imple-
mented in the randomForest R package[9], using the default tuning parameter
specifications.
3.1. Synthetic data-sets
When the training and test sets are obtained by record-wise data split, iden-
tity confounding can arise due to statistical dependencies in the feature data of
each participant (e.g, serial association in longitudinal data), as well as, because
of differences in the average or variance of the feature distributions across the
distinct subjects (even when the longitudinal feature measurements are inde-
pendent of each other). Here, we illustrate the application of our permutation
tests to synthetic data simulated: (i) in the presence of identity confounding,
and absence of disease effect; (ii) in the presence of both identity confounding
and disease effect; and (iii) in the absence of both identity confounding and
disease effect.
We simulate feature data using a model similar to the one employed by Saeb
et al [1], except that we generate the data using matrix-normal distributions,
in order to model the correlation structure across the records and across the
features. (The matrix-normal distribution, over the space of matrices with r
rows and c columns, is parametrized as,
W ∼ MNr×c(M , Σ , Ψ) , (11)
where the r × c matrix M represents the mean of matrix-normal variable W ;
the r × r matrix Σ models the covariance structure across the rows of W ;
and the c × c matrix Ψ models the covariance structure across the columns of
W . As an illustration, Supplementary Figure S1 shows the correlations across
rows and columns for data matrices simulated from 4 distinct matrix-normal
distributions.)
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In our simulations, the feature data matrix from each subject s was generated
independently from all other subjects according to the model,
Xs = µs 1 + a ys 1 + bU s + c σs V s + dEs , (12)
where a, b, c, and d are scalars; µs and σ
2
s represent, respectively, subject specific
mean and variance values (shared by all features); 1 corresponds to a matrix
with Nrs rows and Nf columns filled with 1s; ys represents the subject’s disease
label, assuming the value -1 if the subject is a control and 1 if he/she is a
case; and the matrices U s, V s, and Es are sampled from the matrix-normal
distributions,
U s ∼ MNNrs×Nf (0 , Σ , I) , (13)
V s ∼ MNNrs×Nf (0 , I , I) , (14)
Es ∼ MNNrs×Nf (0 , I , Ψ) , (15)
where we adopt an autoregressive correlation structure for Σ (where each of
its elements is given by σij = ρ
|i−j|
r , with the fixed scalar ρr representing a
correlation coefficient), but a simpler correlation structure for Ψ (where the
diagonal elements are given by 1, and off-diagonal elements are given by the
correlation scalar ρf ).
The component U s induces a correlation structure across the records, while
Es generates correlation across the features. The component V s, on the other
hand, only contributes white noise, since by adopting identity matrices for the
covariances across the records and the features, we have that sampling from
MNNrs×Nf (0, I, I) is equivalent to independently sampling each entry of V s
from a standard normal distribution. Also, because U s, V s, and Es are centered
at 0, the mean of Xs is given by µs 1 + a ys 1.
By varying the scalar values µs, σs, a, b, c, and d in equation (12), we can
simulate data under the null and alternative hypothesis for disease recognition
and identity confounding. Here, we illustrate the application of our permutation
tests in 6 distinct scenarios presented in Figures 4, 5, 6, 7, 8, and 9. Table 1
provides a brief description of the mechanisms giving rise to identity confound-
ing, the hypotheses under which the data was simulated, and the models used
to generate the feature data. Our goal is to illustrate how identity confounding
can arise for many different reasons, and how the proposed permutation tests
are able to detect it.
In all examples, we simulated data for 10 correlated features (ρf = 0.5),
across 20 subjects (13 cases and 7 controls), with the number of records varying
from 10 to 20 records per subject, and adopting ρr = 0.95. We employed 10,000
permutations in the generation of the disease recognition null distribution. The
generation of the identity confounding null distribution, on the other hand, was
based on only 1,000 record-wise feature permutations, with 300 subject-wise
label permutations per record-wise feature permutation due to computational
constraints. (Supplementary Figure S2, provides a justification for our choice of
300 subject-wise label shufflings. It shows that the sampling variability associ-
ated with the adoption of 1,000 record-wise feature permutations overwhelms
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Example Identity confounding Hypotheses (H0 or H1) Model used to simulate
(Figure) generation mechanism consistent with the data the feature data, Xs
Example 1 serial dependency disease recog. null (H∗0 ), 2Us + V s + 0.5Es
(Fig. 4) across records (Us) identity conf. alter. (H
∗∗
1 )
Example 2 serial dependency disease recog. alter. (H∗1 ), ys 1 + 2Us + V s + 0.5Es
(Fig. 5) across records (Us), identity conf. alter. (H
∗∗
1 )
and location shifts
due to disease label (ys)
Example 3 location shifts due disease recog. null (H∗0 ), µs 1 + V s
(Fig. 6) to subject specific identity conf. alter. (H∗∗1 )
mean (µs)
Example 4 location shifts due disease recog. alter. (H∗1 ), ys 1 + V s
(Fig. 7) to disease label (ys) identity conf. alter. (H
∗∗
1 )
Example 5 scale shifts due disease recog. null (H∗0 ), σs V s
(Fig. 8) to subject specific identity conf. alter. (H∗∗1 )
variances (σ2s)
Example 6 no identity confounding disease recog. null (H∗0 ), V s
(Fig. 9) generation mechanism identity conf. null (H∗∗0 )
Table 1
Summary of the synthetic data examples. The first column lists the synthetic data examples
(and the respective figures where they are presented). The second column describes the
mechanisms giving rise to identity confounding in each example. The third describes which
disease recognition hypotheses (H∗0 vs H
∗
1 ) and identity confounding hypothesis (H
∗∗
0 vs
H∗∗1 ) are consistent with each simulated example. The last column describes the respective
models used of simulate the feature data. Further details are provided in the main text.
the small differences in the shape of the identity confounding null achieved by
increasing the number of subject-wise label shufflings beyond 300 permutations.)
In our first synthetic data example, we simulated feature data from the model,
Xs = 2U s + V s + 0.5Es , (16)
where identity confounding arises due to the serial correlation across the records
induced by the U s component. Since, the model does not include a disease effect
(a was set to 0), we have that the data is consistent with the null hypothesis of
the disease recognition permutation test, H∗0 , and with the alternative hypothe-
sis of the identity confounding permutation test, H∗∗1 . Figure 4a shows the ROC
curves for data split in a record-wise (brown) and subject-wise (black) fashion.
Note that the subject-wise split leads to a much smaller AUC value (0.57) than
the record-wise data split (AUC = 0.8). Figure 4b shows boxplots of the feature
data across all 20 subjects, with cases and controls shown in orange and green,
respectively. In this case, we don’t see mean differences between cases and con-
trols, since we simulated featured data centered at 0 (both µs and a are set to
0 in the model shown in equation 16). Figure 4c shows the disease recognition
null distribution (blue), and the observed AUC value, auco, (brown line) for the
record-wise data split. The null distribution is centered away from 0.5 (median
= 0.77), indicating the presence of identity confounding. The disease recognition
permutation p-value (= 0.2984, given by the tail probability of the blue distri-
bution to the right of the brown line), nonetheless, indicates that the classifier is
still unable to perform disease recognition, even though the observed AUC value
(0.8) is high. This observation suggests that the high classification performance
is entirely due to the classifier’s ability to identify subjects. Figure 4d, shows the
identity confounding null distribution (red), and the observed value of the ˜auc∗
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Fig 4. Synthetic data example 1, where the feature data was simulated from model Xs =
2Us +V s + 0.5Es, under the null hypothesis for disease recognition, H∗0 and the alternative
hypothesis for identity confounding, H∗∗1 . Panel a shows the ROC curves and AUC values for
data split in a record-wise (brown) and subject-wise (black) fashion. Panel b shows boxplots
of the feature data across all subjects, with cases and controls shown in orange and green,
respectively. Panels c and d show, respectively, the disease recognition and the identity con-
founding permutation null distributions (blue and red histograms) for the record-wise data
split. The brown line in panel c corresponds to the observed AUC value, while the blue line
and grey curve in panel d show, respectively, the median of the blue histogram in panel c and
the density of the normal distribution used for the computation of the pseudo p-value. Panels
e and f show the analogous objects for the subject-wise data split.
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statistic (blue line), which corresponds to the median of the disease recognition
null distribution shown in panel c. The identity confounding permutation p-
value (computed as the proportion of times that the red distribution was larger
than the blue line) is 0, and confirms the presence of identity confounding when
the data is split in a record-wise fashion. The grey density represents the an-
alytical approximation for the H∗∗∗0 null, used in the computation of the the
pseudo p-value for detecting identity confounding (given by the area under the
grey density to the right of the blue line - which, in this example, is 6× 10−8).
Figure 4e shows the disease recognition null distribution for the subject-wise
data split (blue) and the observed AUC value (black line). Because the subject-
wise split (by construction) eliminates the classifier’s ability to perform subject
identification, this null distribution will always be centered around 0.5. In this
example, again, the disease recognition permutation p-value (0.2781) indicates
that the random forest classifier is is not performing disease recognition. Figure
4f shows the identity confounding null distribution (red) for the subject-wise
data split, and further confirms that this data split avoids identity confounding
issues (permutation p-value = 0.719, pseudo p-value = 0.516).
In our second synthetic data example, we simulate data from the model,
Xs = ys 1 + 2U s + V s + 0.5Es , (17)
which basically adds a disease effect to the model used in the first example.
Hence, the data is now simulated under the alternative hypothesis for disease
recognition, H∗1 , and identity confounding, H
∗∗
1 . Figure 5a shows much higher
AUC values for both record-wise (0.97) and subject-wise (0.95) data splits. Fig-
ure 5b shows clear mean differences between cases and controls (as one would
expect, since we now include a disease effect). Figure 5c shows that, even though
identity confounding is playing a role in the random forest’s classification per-
formance, when the data is split in a record-wise manner (note the shift away
from 0.5 in the blue distribution), the algorithm is, nonetheless, still doing dis-
ease recognition (permutation p-value = 0). Figure 5e, shows that the random
forest is performing disease recognition with the subject-wise data split, as well
(permutation p-value = 0). Figure 5d confirms the presence of identity con-
founding (permutation p-value = 0, pseudo p-value = 0.0024) with record-wise
data split, while Figure 5f confirms it’s absence (permutation p-value = 0.318,
pseudo p-value = 0.487) with subject-wise split.
In our third example, we illustrate how differences in the mean feature values
across the subjects can lead to identity confounding, even when the longitudinal
data of each individual has no serial association structure. To this end, we
simulate data from the model,
Xs = µs 1 + V s , (18)
where the feature data of each subject is independent and identically distributed
(i.i.d.) according to N(µs, 1). Note that in this case the data is simulated un-
der the null for disease recognition, H∗0 , and under the alternative for identity
confounding, H∗∗1 . (Observe, as well, that this model corresponds to the i.i.d.
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Fig 5. Synthetic data example 2, where the feature data is simulated from model Xs =
ys 1+ 2Us + V s + 0.5Es, under the alternative hypothesis for disease recognition, H∗1 , and
the alternative hypothesis for identity confounding, H∗∗1 . Panel a shows the ROC curves and
AUC values for data split in a record-wise (brown) and subject-wise (black) fashion. Panel b
shows boxplots of the feature data across all subjects, with cases and controls shown in orange
and green, respectively. Panels c and d show, respectively, the disease recognition and the
identity confounding permutation null distributions (blue and red histograms) for the record-
wise data split. The brown line in panel c corresponds to the observed AUC value, while the
blue line and grey curve in panel d show, respectively, the median of the blue histogram in
panel c and the density of the normal distribution used for the computation of the pseudo
p-value. Panels e and f show the analogous objects for the subject-wise data split.
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Fig 6. Synthetic data example 3, where the feature data is simulated from model Xs =
µs 1+V s, under the null hypothesis for disease recognition, H∗0 , and the alternative hypoth-
esis for identity confounding, H∗∗1 . Panel a shows the ROC curves and AUC values for data
split in a record-wise (brown) and subject-wise (black) fashion. Panel b shows boxplots of the
feature data across all subjects, with cases and controls shown in orange and green, respec-
tively. Panels c and d show, respectively, the disease recognition and the identity confounding
permutation null distributions (blue and red histograms) for the record-wise data split. The
brown line in panel c corresponds to the observed AUC value, while the blue line and grey
curve in panel d show, respectively, the median of the blue histogram in panel c and the den-
sity of the normal distribution used for the computation of the pseudo p-value. Panels e and
f show the analogous objects for the subject-wise data split.
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mixture model for data clustered by subject, discussed in reference[5].) Figure
6b shows accentuated mean differences in feature values across the subjects, and
Figures 6c and d illustrate how, even though, the record-wise data split leads
to a high AUC value (0.89), the random forest classifier is performing subject
identification only (disease recognition permutation p-value = 0.474, identity
confounding permutation p-value = 0).
Our fourth example, illustrates how the disease effect can itself induce a
certain amount of identity confounding, when the data is split in a record-wise
manner. To this end, we simulated data from the model,
Xs = ys 1 + V s , (19)
where the feature data from case and control subjects is i.i.d. N(1, 1) and
N(−1, 1), respectively. Because the disease label contributes to the mean of the
feature values, and identity confounding can arise because of mean differences
across the subjects (as illustrated in the previous example), we have that, the
data in model (19) is generated under the alternative for disease recognition,
H∗1 , as well as, for identity confounding, H
∗∗
1 . (Observe that, at least for data
simulated according to model (12), it is not possible to generate data under the
alternative for disease recognition and, concomitantly, under the null for identity
confounding.) Figure 7b shows clear mean differences between cases and con-
trols, while Figure 7c shows that the classifier is performing disease recognition
with the record-wise data split (permutation p-value = 0). But, more interest-
ingly, it also illustrates that the disease recognition null is slightly shifted away
from 0.5 (median = 0.55), showing that the difference in means is enough to
generate identity confounding for record-wise data splits. Furthermore, Figure
7d shows that this small shift is statistically significant (identity confounding
permutation p-value = 0). Observe, as well, that this example illustrates the
case where the pseudo p-value (= 0.162) fails to detect identity confounding,
while the permutation p-value does not.
In our fifth example, we illustrate how differences in the variance of the
feature values across the subjects can lead to identity confounding, even when
the longitudinal data of each individual has no serial association structure. To
this end, we simulate data from the model,
Xs = σs V s , (20)
where the feature data of each subject is i.i.d. according to N(0, σ2s), and the
σ2s values were sampled from a uniform distribution in the interval (1, 10). Note
that in this case the data is again simulated under the null for disease recog-
nition, H∗0 , but under the alternative for identity confounding, H
∗∗
1 . Figure 8b
shows clear spread differences between the subjects. Note that although Fig-
ure 8c shows that the classifier is not performing disease recognition with the
record-wise data split (permutation p-value = 0.3088), it illustrates that the
difference in variance is enough to generate identity confounding for record-wise
data splits. Furthermore, Figure 8d shows that this small shift is statistically sig-
nificant (identity confounding permutation p-value = 0). Note, as well, that this
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Fig 7. Synthetic data example 4, where the feature data is simulated from model Xs =
ys 1 + V s, under the alternative hypothesis for disease recognition, H∗1 , and the alternative
hypothesis for identity confounding, H∗∗1 . Panel a shows the ROC curves and AUC values for
data split in a record-wise (brown) and subject-wise (black) fashion. Panel b shows boxplots
of the feature data across all subjects, with cases and controls shown in orange and green,
respectively. Panels c and d show, respectively, the disease recognition and the identity con-
founding permutation null distributions (blue and red histograms) for the record-wise data
split. The brown line in panel c corresponds to the observed AUC value, while the blue line
and grey curve in panel d show, respectively, the median of the blue histogram in panel c and
the density of the normal distribution used for the computation of the pseudo p-value. Panels
e and f show the analogous objects for the subject-wise data split.
Chaibub Neto E. et. al./Detecting identity confounding in diagnostic applications 20
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
1 − specificity
se
n
si
tiv
ity
record−wise data split (AUC = 0.62)
subject−wise data split (AUC = 0.57)
(a)
l
l
−
30
−
10
0
10
20
fe
a
tu
re
 v
a
lu
es
cases
controls
su
bje
ct1
su
bje
ct1
0
su
bje
ct1
1
su
bje
ct1
2
su
bje
ct1
3
su
bje
ct1
4
su
bje
ct1
5
su
bje
ct1
6
su
bje
ct1
7
su
bje
ct1
8
su
bje
ct1
9
su
bje
ct2
su
bje
ct2
0
su
bje
ct3
su
bje
ct4
su
bje
ct5
su
bje
ct6
su
bje
ct7
su
bje
ct8
su
bje
ct9
l
l
l
l
l
l
−
30
−
10
0
10
20
l
l
l
l
l
l
l
l
−
30
−
10
0
10
20
l
l
l
l
l
−
30
−
10
0
10
20
l
l
l
l l
l
l
l
l l
l
−
30
−
10
0
10
20
l
l
l
l
l
l
l
−
30
−
10
0
10
20
l
l
l
l
l
l
l
l
−
30
−
10
0
10
20
l
l
l
l
l
l
−
30
−
10
0
10
20
l
l
l
−
30
−
10
0
10
20
ll
l
l
l
−
30
−
10
0
10
20
(b)
AUC
D
en
si
ty
0
2
4
6
8 disease recognition null
(c)
record−wise train/test data split
D
en
si
ty
0.0 0.2 0.4 0.6 0.8 1.0
0
10
30
50
subject identification null
(d)
test statistic
AUC
D
en
si
ty
0
2
4
6
8 disease recognition null
(e)
subject−wise train/test data split
D
en
si
ty
0.0 0.2 0.4 0.6 0.8 1.0
0
20
60
10
0
subject identification null
(f)
test statistic
Fig 8. Synthetic data example 5, where the feature data is simulated from model Xs = σs V s,
under the null hypotheses for disease recognition, H∗0 , and identity confounding, and the
alternative hypothesis for identity confounding, H∗∗1 . Panel a shows the ROC curves and
AUC values for data split in a record-wise (brown) and subject-wise (black) fashion. Panel b
shows boxplots of the feature data across all subjects, with cases and controls shown in orange
and green, respectively. Panels c and d show, respectively, the disease recognition and the
identity confounding permutation null distributions (blue and red histograms) for the record-
wise data split. The brown line in panel c corresponds to the observed AUC value, while the
blue line and grey curve in panel d show, respectively, the median of the blue histogram in
panel c and the density of the normal distribution used for the computation of the pseudo
p-value. Panels e and f show the analogous objects for the subject-wise data split.
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Fig 9. Synthetic data example 6, where the feature data is simulated from model Xs = V s,
under the null hypotheses for disease recognition, H∗0 , and identity confounding, H
∗∗
0 . Panel
a shows the ROC curves and AUC values for data split in a record-wise (brown) and subject-
wise (black) fashion. Panel b shows boxplots of the feature data across all subjects, with cases
and controls shown in orange and green, respectively. Panels c and d show, respectively,
the disease recognition and the identity confounding permutation null distributions (blue and
red histograms) for the record-wise data split. The brown line in panel c corresponds to the
observed AUC value, while the blue line and grey curve in panel d show, respectively, the
median of the blue histogram in panel c and the density of the normal distribution used for
the computation of the pseudo p-value. Panels e and f show the analogous objects for the
subject-wise data split.
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example illustrates the case where the pseudo p-value (= 0.069) is marginally
significant, while the permutation p-value clearly indicates the presence of iden-
tity confounding.
In our sixth example, we consider the null model,
Xs = V s , (21)
where all the feature data within and across all participants is i.i.d. N(0, 1), so
that the data is simulated under the null hypothesis for disease recognition, H∗0 ,
and identity confounding, H∗∗0 . As expected, Figure 9 shows that the random
forest classifier is not performing disease recognition or subject identification,
no matter how the data is split.
Finally, as a sanity check, we performed a simulation study using 500 distinct
data-sets simulated under the null for both disease recognition and identity
confounding. Supplementary Figure S3 reports the results and describes the
simulation experiment in more detail. As expected, the distribution of the p-
values is approximately uniform for the permutation tests, indicating that the
type I error rates are being controlled at the nominal significance levels. The
pseudo p-value distributions, on the other hand, are bell shaped and centered
around 0.5, indicating that the pseudo p-value approach is conservative at small
nominal significance levels (that is, the pseudo p-values tend to be larger than
they should be), illustrating, once again, that a small pseudo p-value implies
the presence of identity confounding, whereas non-significant pseudo p-values
do not imply the absence of digital fingerprints.
3.2. Real data illustrations
We illustrate the application of our proposed tests to the diagnosis of Parkinson’s
disease (PD), using iPhone sensor data collected during the first six months of
the mPower study[10, 11]. We focus our analyses on data collected from the
voice and tapping activity tasks (details about the activity tasks are provided
in reference[11]).
Our analyses were based on a matched sample of 11 PD patients and 11
control participants, who provided at least 100 records over the 6 month pe-
riod. All case and control participants were males, and were first matched by
age (using exact matching), and then by education level (using nearest neigh-
bor matching[12]) whenever there were multiple cases with the same age of a
control, or vice-versa. (In the event that ties persisted after the application of
this second matching criterion, we randomly selected one participant to perform
the matching.) We trained separate random forest classifiers for the voice and
tapping data, based on 13 voice features and 41 tapping features proposed in
the literature[13, 14].
Due to the small number of subjects, in order to maintain balance in the age
distributions of cases and controls in the training and test sets, we performed an
age balanced version of the subject-wise data split (where whenever the training
set contained a case of a given age, then the test set contained the matched
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control of the same age, and vice versa). For the record-wise data split, on the
other hand, we simply randomly selected the records. (Note that because each
subject has a large number of records (at least one hundred), the distribution
of the ages tends to be well balanced between cases and controls in both the
training and test sets.)
Figure 10 shows the results for the voice data. From panel a we observe
a massive amount of identity confounding for the record-wise split data, with
the disease recognition null distribution (blue) concentrated at very high AUC
values (median AUC = 0.954). Both the identity confounding permutation p-
value and the pseudo p-value are 0 in this example. The disease recognition
p-value (= 0.5843), on the other hand, shows that the random forest classifier is
not performing disease recognition, even though the observed AUC (brown line)
is 0.952. Panel b reports the results for the subject-wise data split, and show
that, once again, the classifier is not learning about the disease labels (disease
recognition p-value = 0.7243).
In order to assess the robustness of these results with respect to the train-
ing/test data split, we show in panel c the disease recognition null distributions
(blue boxplots) for 30 distinct record-wise data splits, as well as, the respective
AUC values (brown dots), and the distribution of the disease recognition per-
mutation p-values across the 30 data splits (brown boxplot). The results show
that in none of the 30 data splits we observed a permutation p-value smaller
than 0.05 (dashed red line), showing that the very high AUC values (brown
dots) achieved by the classifier are due largely to the classifier’s ability to iden-
tify subjects. Finally, panel d reports the results for the subject-wise data split,
confirming that the classifier is indeed unable to perform disease recognition.
Figure 11 shows the results for the tapping data. Again from panel a we
observe high levels of identity confounding for the record-wise data split (iden-
tity confounding permutation p-value and the pseudo p-value are again 0), but
contrary to the voice data, the random forest classifier is now able to per-
form disease recognition with the tapping features (disease recognition p-value
= 0.014). Panel b, shows that the classifier trained with the subject-wise data
split is still able to perform disease recognition, although the statistical signif-
icance is weaker (permutation p-value = 0.055). Panel c shows that the results
presented in panel a are robust across distinct record-wise data splits. Panel
d assesses the robustness of the findings observed in panel b, and shows that
results tend to be more variable and less significant in this case when compared
to the record-wise data splits (note how the distribution of the disease recogni-
tion p-values have a larger spread than in the record-wise case). We point out,
nonetheless, that this larger variability is likely due to the very small number of
subjects and the heterogeneous nature of the data, and suggests that a certain
amount of model under-fitting is going on in the tapping data.
In order to assess whether a larger number of subjects would improve the
power to perform disease recognition (especially when adopting the subject-
wise data split strategy) we repeated our analysis using a larger number of
subjects (who, nonetheless, provided a smaller number of records). Specifically,
for the voice data we analyzed two additional (age matched and male) cohorts
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Fig 10. Voice data example. Panel a shows the disease recognition permutation null (blue)
the observed AUC value (brown line), the identity confounding permutation null distribution
(red), and the density of the analytical null distribution used for the computation of the
pseudo p-values, for the record-wise data split. Panel b shows the analogous objects for the
subject-wise data split. Panel c reports the disease recognition null distributions (blue boxplots)
for 30 distinct record-wise data splits, as well as, the observed AUC values (brown dots),
and the distribution of the disease recognition permutation p-values across the 30 data splits
(brown boxplot). Panel d shows the analogous objects for the subject-wise data split. The
disease recognition nulls was generated with 10,000 permutations in panels a and b, and
1,000 permutations in panels c and d. The identity confounding nulls were generated with
1,000 feature permutations (and 300 label permutations per feature permutation).
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Fig 11. Tapping data example. Panel a shows the disease recognition permutation null (blue)
the observed AUC value (brown line), the identity confounding permutation null distribu-
tion (red), and the density of the analytical null distribution used for the computation of the
pseudo p-values, for the record-wise data split. Panel b shows the analogous objects for the
subject-wise data split. Panel c reports the disease recognition null distributions (blue box-
plots) for 30 distinct record-wise data splits, as well as, the observed AUC values (brown
dots), and the distribution of the disease recognition permutation p-values across the 30 data
splits (black boxplot). Panel d shows the analogous objects for the subject-wise data split. The
disease recognition nulls was generated with 10,000 permutations in panels a and b, and 1,000
permutations in panels c and d. The identity confounding nulls were generated with 1,000
feature permutations (and 300 label permutations per feature permutation).
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record−wise split, 42 subjects
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record−wise split, 240 subjects
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Fig 12. Comparison of the disease recognition performance in the voice data, across increasing
number of subjects. Panels a, b, and c, show the disease recognition null distributions (blue
boxplots), across 30 distinct record-wise data splits, for classifiers trained and evaluated using,
respectively, 22 subjects (with at least 100 records per subject), 42 subjects (with at least 50
records per subject), and 240 subjects (with at least 10 records). The brown dots represent
the observed AUC values. Observe the decrease in AUC, as the number of subjects increase.
Panels d, e, and f, show the analogous results for 30 distinct subject-wise data splits (with
black dots representing the observed AUC values). Note the decrease in the spread of the
disease recognition null distributions, as the number of subjects increases. (Observe, as well,
the different y-axis scales of panels a, b, and c, when compared to panels d, e, and f.) Panel g
shows the distributions of the disease recognition permutation p-values, across the 30 random
data splits shown in panels a to f. Note that in none of the data splits the permutation p-
value was smaller than 0.05 (red line), showing that the classifier is unable to perform disease
recognition with the adopted voice features.
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(a)
record−wise split, 48 subjects
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(b)
record−wise split, 290 subjects
AU
C
0.80
0.85
0.95
1.00
ru
n
1
ru
n
2
ru
n
3
ru
n
4
ru
n
5
ru
n
6
ru
n
7
ru
n
8
ru
n
9
ru
n
10
ru
n
11
ru
n
12
ru
n
13
ru
n
14
ru
n
15
ru
n
16
ru
n
17
ru
n
18
ru
n
19
ru
n
20
ru
n
21
ru
n
22
ru
n
23
ru
n
24
ru
n
25
ru
n
26
ru
n
27
ru
n
28
ru
n
29
ru
n
30
l l l
l l l l l
l l l l l
l l
l l l l
l l l l
l l l l l l l
(c)
0.0
0.2
0.4
0.6
0.8
1.0
subject−wise split, 22 subjects
AU
C
ru
n
1
ru
n
2
ru
n
3
ru
n
4
ru
n
5
ru
n
6
ru
n
7
ru
n
8
ru
n
9
ru
n
10
ru
n
11
ru
n
12
ru
n
13
ru
n
14
ru
n
15
ru
n
16
ru
n
17
ru
n
18
ru
n
19
ru
n
20
ru
n
21
ru
n
22
ru
n
23
ru
n
24
ru
n
25
ru
n
26
ru
n
27
ru
n
28
ru
n
29
ru
n
30
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
(d)
0.0
0.2
0.4
0.6
0.8
1.0
subject−wise split, 48 subjects
AU
C
ru
n
1
ru
n
2
ru
n
3
ru
n
4
ru
n
5
ru
n
6
ru
n
7
ru
n
8
ru
n
9
ru
n
10
ru
n
11
ru
n
12
ru
n
13
ru
n
14
ru
n
15
ru
n
16
ru
n
17
ru
n
18
ru
n
19
ru
n
20
ru
n
21
ru
n
22
ru
n
23
ru
n
24
ru
n
25
ru
n
26
ru
n
27
ru
n
28
ru
n
29
ru
n
30
l
l
l
l
l
l
l
l
l
l
l
l
l l
l l
l
l
l
l
l
l
l
l
l
l
l l
l
l
(e)
0.0
0.2
0.4
0.6
0.8
1.0
subject−wise split, 290 subjects
AU
C
ru
n
1
ru
n
2
ru
n
3
ru
n
4
ru
n
5
ru
n
6
ru
n
7
ru
n
8
ru
n
9
ru
n
10
ru
n
11
ru
n
12
ru
n
13
ru
n
14
ru
n
15
ru
n
16
ru
n
17
ru
n
18
ru
n
19
ru
n
20
ru
n
21
ru
n
22
ru
n
23
ru
n
24
ru
n
25
ru
n
26
ru
n
27
ru
n
28
ru
n
29
ru
n
30
l
l
l l l
l l
l
l
l
l
l
l l
l l
l l l
l
l
l
l l
l
l
l l l
l
(f)
l
l
l
l
l
l
ll
22 subjects 48 subjects 290 subjects 22 subjects 48 subjects 290 subjects
0.00
0.05
0.10
0.15
0.20
0.25
0.30
p−value distributions across the 30 random data splits
p−
va
lu
e
record−wise data split
subject−wise data split (g)
Fig 13. Comparison of the disease recognition performance in the tapping data, across in-
creasing number of subjects. Panels a, b, and c, show the disease recognition null distributions,
across 30 distinct record-wise data splits, for classifiers built with, 22 subjects (with at least
100 records per subject), 48 subjects (with at least 50 records per subject), and 290 subjects
(with at least 10 records), respectively. The brown dots represent the observed AUC values.
Observe the decrease in AUC, as the number of subjects increase. Panels d, e, and f, show
the analogous results for 30 distinct subject-wise data splits (with black dots representing the
observed AUC values). Note the decrease in the spread of the disease recognition null distri-
butions, as the number of subjects increases. Panel g shows the distributions of the disease
recognition permutation p-values, across the 30 random data splits shown in panels a to f.
Note how the p-values tend to decrease, as the number of subjects increase. In particular,
the accentuated improvement in power for the subject-wise split strategy (black boxplots),
illustrates how the increase in the number of subjects reduced to a great extent the model
under-fitting issue observed in panel d.
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containing 42 subjects (who provided at least 50 records), and 240 subjects (who
contributed at least 10 records), whereas for the tapping data we analyzed two
additional cohorts containing 48 and 290 subjects (who contributed at least 50
and 10 records, respectively). As before, we ran the analyses on 30 distinct data
splits, with half of the subjects and (approximately) half of the records assigned
to training set in the subject-wise and record-wise data splits, respectively.
Figure 12 reports the results for the voice data. Panels a, b, and c show the
disease recognition null distributions and observed AUC values for the record-
wise data splits across increasing numbers of subjects. In all 3 panels, the disease
recognition null distributions are concentrated around very high AUC values,
suggesting that identity confounding is playing an important role in all three
cohorts. It is interesting to note that the AUC values tended to decrease, as the
amount of data used to train the random forests increased. This drop in AUC
is, nevertheless, not surprising, given that the classifier is mostly performing
subject identification and that a larger number of subjects makes it harder to
identify the individual subjects. Observe, as well, that the random forest only
started to detect the disease signal in panel c, where a larger amount of data was
available to train the classifier (note how the brown dots started to approach
the upper tail of the blue boxplots). Panels d, e, and f, show analogous results
for the subject-wise data splits. Note that, as expected, the disease recognition
null distributions were always centered around 0.5, and their spread tended
to decrease as the number of subjects increased. Observe, nonetheless, that the
random forest was unable to perform disease recognition even when the training
set contained data from 120 subjects (panel f). Panel g shows the distributions
of the disease recognition permutation p-values, across the 30 random data splits
shown in panels a to f.
Figure 13 shows the results for the tapping task. Overall, we observe the same
patterns as for the voice data, except that tapping features seem to be less prone
to perform subject identification (comparison of panels a, b, and c on Figures
13 and 12 show that both the observed AUC values and disease recognition null
distributions tend to be located at lower AUC values for the tapping data than
for the voice data), and are better able to perform disease recognition in both
record-wise and subject-wise data splits (compare Figures 13g and 12g).
4. Discussion
In this paper, we propose the use of permutation tests to detect identity con-
founding in clinical machine learning applications. By focusing on non-parametric
hypothesis tests, instead of the more difficult task of generalization error es-
timation via cross-validation, we are able to statistically test if the classifier
is performing disease recognition and/or subject identification, even in situa-
tions where the cross-validation error estimates are unreliable due to assumption
violations[5].
We illustrate the application of the proposed tests with synthetic data, as
well as, with real data from a Parkinson’s disease study[11, 10]. While our il-
lustrations are all based on the AUC metric, these permutation tests can be
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implemented with other performance metrics. Also, even though this paper fo-
cuses primarily on diagnostic applications, our permutation tests can be applied
in other binary classification problems (in which case the “disease recognition”
null distribution should be just renamed as the “label recognition” null). Fur-
thermore, these tests can also be readily applied to multi-class problems, by
simply adopting a multi-class performance metric as a test statistic for the la-
bel recognition null, and the median of the label recognition null as the test
statistic for the identity confounding null. (Note that the subject-wise label
shuffling used to generate the label recognition null is essentially the same as in
the binary case, except that instead of the two colors representing the case and
control labels in Figures 1 and 2, we would have as many colors as the number
of classes.)
The main drawback of the proposed identity confounding permutation test
is the large amount of computation required to generate the null distribution
(recall that the computation of the test statistic requires pl subject-wise label
permutations, and we need to generate this statistic p times, leading to a total
of p × pl computations). However, as illustrated in Supplementary Figure S2,
it is possible to adopt a smaller number of subject-wise label permutations,
than of record-wise feature permutations, without sacrificing the accuracy of
the results. Still, another strategy to reduce computation is to first compute
the “pseudo p-value” described in Section 2.3, to see if it is even necessary
to compute the permutation p-value. (As a matter of fact, the pseudo p-values
alone, would have been enough to establish the presence of identity confounding
in our analyses of the mPower data.) Observe, however, that the pseudo p-value
shortcut is only available for the AUC metric, and cannot be used with other
binary classification or multi-class performance metrics.
For illustration purposes, we applied the identity confounding permutation
test to both record-wise and subject-wise data splits. In practice, however, it is
not necessary to test for identity confounding when adopting subject-wise data
splits, as the influence of any digital fingerprints are automatically neutralized
by the subject-wise strategy. Hence, in practice, we recommend the following
steps to determine which data split strategy is the most sensible to assess clas-
sification performance in the data-set at hand. Starting with record-wise data
splits, run the disease recognition permutation test in order to informally assess
if identity confounding is playing a role. Next, test for the presence of identity
confounding using the pseudo p-value. If identity confounding is detected, then
the subject-wise data split should be used. Otherwise, if the pseudo p-value
does not support the presence of identity confounding, or if a metric other than
the AUC is being used, run the computationally expensive identity confounding
permutation test. If identity confounding is not detected, then the record-wise
data split can be safely used to assess the classifier performance. Otherwise,
run the disease recognition permutation test using the subject-wise data split
in order to assess classification performance.
In addition to the data exchangeability assumption (required by any permu-
tation test) our tests also implicitly assume that the classifier is properly tuned,
so that an inability to perform disease recognition or subject identification is
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really due to the lack of signal in the data, and not poor algorithm tuning. Note
that in our analyses, we adopt the random forest classifier, which requires min-
imal amounts of tuning, while still achieving similar classification performance
to other classifiers that require much more careful tuning.
Ours tests are designed to detect identity confounding only. Of course, other
sources of confounding (e.g., age and sex) can still play a role in the classification
performance, and need to be dealt with before running the permutation tests.
In the mPower study, the age distributions of cases and controls are not well
balanced (with the control population being younger than the PD cases popu-
lation). Hence, in our analyses, we adopted a subset of age matched case and
control participants. Furthermore, because very few female participants con-
tributed enough records, we restricted our analyses to male participants only.
(We point out, that had we not matched the subjects by age, we would not
be able to tell whether the disease recognition permutation test was perform-
ing disease recognition or “age recognition” of young versus old participants,
or still both disease and age recognition. In any case, the identity confounding
permutation test would still be able to detect the presence of digital fingerprints
since age would be confounded with the disease labels, but not with the subject
identities.)
Our synthetic data examples clearly illustrate that identity confounding may
arise: (i) when the feature distributions have similar shapes across the subjects,
but show serial dependencies across the records within each subject (as illus-
trated in Figure 4b); as well as, (ii) when the data shows differences in location
and/or spread, but no serial association across the records (as illustrated in Fig-
ures 7b and 8b). Furthermore, we were only able to avoid identity confounding
with data simulated under the very special setting where the feature data was
independent and identically distributed within and across all subjects (and we
could not conceive of a data generation mechanism that could be used to simu-
late data consistent with both the alternative hypothesis for disease recognition
and the null hypothesis for identity confounding). Note, nonetheless, that we
do not make any claims that the particular model adopted to simulate the fea-
ture data is able to closely reproduce the dependency/distributional structures
observed in real mobile data (as any simulated example will always be artifi-
cial to some extent). Rather, the key point we wanted to communicate is that
many different sources of heterogeneity in the feature data can easily give rise
to identity confounding (and that our permutation tests are able to detect it).
The important practical implication, is that identity confounding might turn
out to be the rule, rather than the exception, in digital health studies, since it
seems reasonable to expect that feature data from real applications will likely
show some amount of heterogeneity across subjects.
In particular, our analyses of the voice and tapping data, collected by the
mPower study, showed undeniable evidence of a high degree of identity con-
founding for classifiers built using record-wise data splits. Although it is true
that our results also showed evidence of model under-fitting for classifiers trained
with subject-wise data splits, we point out that model under-fitting can be ame-
liorated by simply increasing the number of subjects used in the analyses. (The
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rationale is that, as the number of subjects used to train the classifier increases,
the chance that the training set is missing a critical part of the pattern that re-
lates features to disease labels decreases, so that the classifier has a better chance
to generalize to new unseen cases, even when the data is fairly heterogeneous).
But, most importantly, our data does not support the hypothesis raised in Little
et al [5] that model under-fitting (alone), rather than identity confounding, could
explain the discrepancy in classification performance between the record-wise
and subject-wise strategies.
Interestingly, the voice data seems to require a much larger number of subjects
in order to perform disease recognition. The fact that the random forest classi-
fier was unable to perform disease recognition with the subject-wise data splits,
and only started to detect the disease signal with record-wise data splits when
the training set contained over 100 subjects, combined with the fact that the
voice-based classifier achieved higher AUC values than the tapping-based one in
the record-wise data splits, suggests that our voice features are more vulnerable
to identity confounding and less suited to perform disease recognition, when
compared to the tapping features. A possible explanation, is that voice features
are intrinsically better able to capture personal and physiological characteristic
of a subject compared to a game based tapping feature. An alternative explana-
tion, is that the weaker disease recognition signal might be due to suboptimal
processing and cleaning of the voice raw data. To see why, note that the digital
fingerprint of a subject may arise not only from biological characteristics, such
as the pitch of a subject’s voice, but also from non-biological/environmental ar-
tifacts, such as the amount of background noise and the distance of the subject’s
mouth to the phone’s microphone. These non-biological artifacts can certainly
contribute to identify subjects when the voice tasks are performed under dif-
ferent conditions across the subjects, but under consistent conditions within
each subject. (Note that while this issue can be somewhat controlled in labora-
tory experiments, this is not generally the case in mobile health studies, such
as mPower, that are conducted at home under uncontrolled conditions.) This
problem is likely exacerbated by the use of highly sensitive sensors, capable of
detecting quite subtle variations in sound. The tapping task, on the other hand,
seems to provide less room for environmental artifacts.
Any source of identity confounding, be it a biological signal or an environ-
mental artifact, is automatically neutralized by the subject-wise data splitting
strategy. It is certainly true that the adoption of the subject-wise data split in
applications based on multiple records from a small number of subjects can lead
to model under-fitting. However, it seems natural that a classifier trained on a
small number of subjects, won’t generally be able to achieve a stellar classifica-
tion accuracy, and that one should not expect to achieve state-of-the-art disease
recognition performance using only a handful of case and control subjects. Fur-
thermore, as already discussed above, model under-fitting can be reduced by
increasing the number of subjects used to train the classifier.
In view of all the points discussed above, we expect that identity confounding
will be a common occurrence in diagnostic digital health applications, and that,
in general, the subject-wise split will be the most sensible data splitting strategy
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for diagnosis (in agreement with the recommendations in Saeb et al [1], Sarkar et
al [2, 3] and Chaibub Neto et al [4]). In any case, we would still suggest, as a best
practice, to always test for the presence of identity confounding in record-wise
data splits (if only to confirm its existence, and empirically justify the adoption
of the subject-wise splitting). An interesting follow up study (that is out of the
scope of the present paper, and is left as future work) would be to apply the
proposed permutation tests to several publicly available mobile health data-sets,
and empirically assess the frequency and strength of the identity confounding
issue in digital health studies.
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Fig S1. Examples of correlation structures generated with the matrix-normal distribution.
The top and bottom panels show, respectively, the correlation structure across the rows and
columns, for data matrices of dimension 100 × 50 sampled from 4 distinct matrix-normal
distributions (listed above the heatmaps). Lighter colors represent stronger correlation values.
In all examples, we adopted ρr = 0.95, and ρf = 0.5 (see Section 3.1). Panels a and e
illustrate the case where the data was generated without correlation structures across the rows
and columns. Panels b and f depict the case with serial correlation structure across the rows,
but no correlation across the columns. Panels c and g, illustrate the case with correlation
across the columns, but not across the rows. Finally, panels d and h, depict the case with
correlation structure across both rows and columns.
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Fig S2. Determination of a sufficient number of subject-wise label permutations in the gener-
ation of the identity confounding null distribution. As described in Algorithm 2, in the main
text, the generation of the identity confounding null distribution requires the computation of
the disease recognition null distribution (which is based on pl subject-wise label shufflings), for
each one of the p record-wise feature data permutations, so that the total number of computa-
tions is given by p× pl. Note, nonetheless, that because the test statistic (m˜∗) corresponds to
the median of a performance metric (m∗), we don’t need to use a large number of label per-
mutations, pl (since it is reasonable to expect that the median of the disease recognition null
distribution, computed with, say, 1,000 subject-wise label permutations should be close to the
median computed with 10,000 permutations). This rationale suggests, that we might be able to
determine a sufficient number of label permutations, by computing the identity confounding
null distribution using increasing pl values, and inspecting when the null distribution “sta-
bilizes”. Panel a shows the standard deviation of the identity confounding null distribution
(red dots) computed with p = 10, 000 record-wise feature permutations for pl varying from
10 to 500 subject-wise label permutations. The black boxplots show the distributions of the
standard deviations across 10,000 sub-samples of size 1,000 of the respective identity con-
founding null distributions, and provide estimates of the amount of sampling variability we
should expect when we adopt 1,000 record-wise feature permutations, rather than 10,000. The
panel shows that, while the standard deviation estimates based on p = 10, 000 permutations
(red dots) are still monotonically decreasing as pl increases, the sampling variability that we
see when we adopt p = 1, 000 by far overwhelms the small difference in standard deviation
that is achieved by increasing pl from 300 to 400 (or 500). Similarly, panel b shows that
the identity confounding null distribution tends to stabilize as the number of label permuta-
tions increases, and panel c shows that the null distributions are already very similar when we
adopt pl = {300, 400, 500}. All the results were based on data simulated according to synthetic
example 1 (equation 16), in the main text.
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Fig S3. Assessing type I error rate control with a simulation study. We simulated 500 distinct
data-sets under the null hypothesis of both the disease recognition and the identity confounding
tests. For each synthetic data-set, the feature data of each subject was independently simulated
according to the model, Xs = cV s+dEs, in order to allow for correlation across the features
(see main text for further details). Each simulated data-set was generated with a unique com-
bination of simulation parameters, with the scalars c and d varying from 0.1 to 2, the number
of cases and controls varying from 5 to 10, and the number of records per participant varying
from 10 to 20. In order to select parameter values spread as uniformly as possible over the en-
tire parameter ranges, we adopted a Latin hypercube space filling design in the determination
of the parameter values used to generate each data-set. Due to computational constraints, the
permutation tests were based on 100 permutations. The top panels show the results from tests
applied to data-sets split in a the record-wise fashion, while the bottom panels report the re-
sults based on subject-wise data splits. Panels a and e show the p-value distributions from the
disease recognition permutation test, while panels b and f show the p-value distributions from
the identity confounding permutation test. As expected, the distributions are approximately
uniform showing that the type I error rate of the permutation tests are being controlled at the
nominal significance levels. Panels c and g show the distributions of the pseudo p-values. As
expected, the distributions are bell-shaped since a central limit theorem for the sample median
of a random variable is kicking in (note that because the pseudo p-value is computed using
the median of the AUC metric, and the tail probability computed with the median of a sample
of test statistics is equal to the median of the tail probabilities computed for each test statistic
in the sample, that is, 1−Φ((medianj{auc∗j}−0.5)/φ) = medianj{1−Φ((auc∗j −0.5)/φ)}, we
have that the pseudo p-value distributions actually correspond to the distributions of the sam-
ple median of disease recognition p-value distributions). Finally, panels d and h, report the
p-value distributions from the analytical test for the presence of disease recognition and/or
identity confounding (H∗∗∗0 ) calculated according to expression (8), in the main text. As
expected, the p-value distributions are also approximately uniform.
